What medicine does bone cancer take when terminal painful

Update Date: 2024-07-23 Source: Network

summary

After the occurrence of chronic diseases such as bone tumor, it will indeed affect the health of patients. For bone tumor diseases, we should not ignore the treatment. We must make good treatment as soon as possible when we are sick. As a more complex disease, what medicine can we take when bone cancer is in late pain?

What medicine does bone cancer take when terminal painful

Drug 1: adriamycin: it is an aminoglycoside antibiotic extracted from the fermentation broth of Streptomyces strain. It has a wide anti-tumor spectrum and is most sensitive to S-phase cells. Suitable for soft tissue sarcoma, osteosarcoma, Ewing sarcoma, rhabdomyosarcoma, etc. The dosage was 60 mg / m2, 2 days. The toxic effects on blood system and heart should be paid attention to.

Drug 2: doxorubicin pyran: its mechanism of action and indications are similar to doxorubicin, and it is also effective for doxorubicin resistant tumor cells. The main side effects were in the blood system, and the cardiac toxicity was less than that of adriamycin.

Drug 3: epirubicin: the difference between epirubicin and doxorubicin is that the 4-hydroxyl group in the amino sugar part changes from cis to trans. The curative effect is not different from that of doxorubicin, and its toxicity to heart and bone marrow is significantly reduced. The mechanism and indications are similar to adriamycin. The dosage is 60-90mg / m2 for single administration or 40-50mg / m2 for two days.

matters needing attention

Warm reminder: drink less milk. The content of iron in milk is low, but the content of calcium and phosphorus is high. Iron in the body is easy to combine with calcium and phosphorus in milk to form insoluble iron compounds, which makes the iron content in the body more insufficient. Drink less tea. Tannic acid in tea is easy to combine with low valent iron to form insoluble iron tannate, which hinders iron absorption. Iron deficiency in human body will reduce hemoglobin synthesis and aggravate the symptoms of anemia.